• Conexeu Sciences launched an incentive program for early exercise of up to 4,762,780 warrants at USD 2.30 per share.
• Holders exercising by April 30, 2027, can purchase one transferable inducement warrant for USD 0.001 per warrant exercised.
• Each inducement warrant permits purchase of one common share at USD 3 for 24 months from issuance.
• Shares issuable through inducement warrant exercises are capped at 2,563,389 on a first-to-exercise basis pending stockholder approval.
• The company will register for resale shares already received from existing warrant exercises, including shares issued through the incentive program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005569), on October 27, 2026, and is solely responsible for the information contained therein.